Dazodalibep
Horizon Therapeutics
['dazodalibep', '$hznp']
$hznp presentations at the 2023 eular european congress of rheumatology highlight new results from phase 2 trial evaluating dazodalibep in sj gren s syndrome - 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities